Stay updated on Immunotherapy with TIL in Metastatic Melanoma Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy with TIL in Metastatic Melanoma Clinical Trial page.

Latest updates to the Immunotherapy with TIL in Metastatic Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange Detected- Site revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page. This change does not alter study content or user-facing features.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded Revision: v3.4.2 and removed the previous government funding lapse notice (Revision: v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check62 days agoChange DetectedAdded a notice about a lapse in government funding and the NIH Clinical Center's operating status. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check69 days agoChange DetectedAdd glossary display and new QC/label elements: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data' capitalization, and 'Revision: v3.4.0'. Deletions remove the older lowercase labels 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' along with the older 'Revision: v3.3.4'.SummaryDifference0.2%

- Check83 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4; this appears to be a minor system update with no change to the study details presented.SummaryDifference0.0%

Stay in the know with updates to Immunotherapy with TIL in Metastatic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy with TIL in Metastatic Melanoma Clinical Trial page.